Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

BSH 2017 | Prospect of new therapies for AML

Mhairi Copland • 29 Mar 2017
BSH 2017
Acute Myeloid Leukemia

Mhairi Copland, PhD, MB, ChB, MRCP, FRCPath from the University of Glasgow, Glasgow, UK, gives an overview of the session on targeted therapy and immunotherapy for acute myeloid leukemia (AML) at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. Prof. Copland discusses clinical trials in the UK and the prospect of new therapies for AML.

More from Mhairi Copland

Co-targeting in CML: practical considerations & the potential of the bone marrow microenvironment 3:00
Co-targeting in CML: practical considerations & the potential of the bone marrow microenvironment
Mhairi Copland • 4 Sep 2025
How the management of CML is evolving & future directions 1:18
How the management of CML is evolving & future directions
Mhairi Copland • 5 Sep 2025
Current and future treatment strategies for blast-phase CML 3:05
Current and future treatment strategies for blast-phase CML
Mhairi Copland • 29 Sep 2022
The importance of improving treatment-free remission in patients with CML 1:36
The importance of improving treatment-free remission in patients with CML
Mhairi Copland • 29 Sep 2022

Related Videos

The value and mission of the International Workshop on Acute Leukemias 14:36
The value and mission of the International Workshop on Acute Leukemias
Charles Craddock et al. • 21 Oct 2025
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years? 1:30
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years?
Koichi Takahashi • 26 Sep 2025
One big question with Naval Daver: what AML advance could transform frontline care in three years? 1:05
One big question with Naval Daver: what AML advance could transform frontline care in three years?
Naval Daver • 26 Sep 2025
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? 3:13
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?
Charles Craddock • 26 Sep 2025
The content of VJHemOnc is intended for healthcare professionals